MedPath

Comparison of the therapeutic effect of metformin and insulin in diabete

Phase 3
Conditions
Gestational diabetes mellitus.
Diabetes mellitus arising in pregnancy
O24.4
Registration Number
IRCT20220817055738N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Fasting blood glucose (92-125 mg/dl),,
1-hour blood glucose = 180 mg/dl after 75 grams of oral glucose
2-hour blood glucose (153-199 mg/dl) after 75 grams of oral glucose

Exclusion Criteria

Women for whom metformin is contraindicated
Diagnosed fetal anomaly
Rupture of the fetal membrane at the time of entering the study
Presence of any other medical condition

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood sugar level. Timepoint: Fasting blood sugar and postprandial blood sugar of the participants were monitored weekly. A comparison of the blood sugar level measured with a glucometer and plasma blood sugar was made to check the accuracy of the stated blood sugar level. Method of measurement: Glucometer and plasma blood sugar.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath